KC
GBT

Kellner Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Kellner Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,235
Closed -$2.26M – 52
2022
Q3 		$2.26M Buy
+33,235
New +$1.83M 1.28% 24

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kellner Capital's GBT Position: Q4 2022 in Review

Kellner Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 33,235 shares — an estimated $2.26M sold.

Kellner Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $2.26M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Kellner Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Kellner Capital sold 33,235 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2.26M.
  • Kellner Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Kellner Capital's Global Blood Therapeutics, Inc. position peaked at $2.26M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Kellner Capital's 13F filing for Q4 2022, filed 13 Feb 2023.